A quantitative study of the effects of a dual layer coating drug-eluting stent on safety and efficacy

被引:1
作者
Guo, Bao [1 ,2 ]
Chen, Shiliang [1 ,2 ]
Zhang, Yu [1 ,2 ]
Yang, Yujia [1 ,2 ]
Song, Hongfang [3 ]
Zhang, Yanping [1 ,2 ]
Du, Tianming [1 ,2 ]
Qiao, Aike [1 ]
机构
[1] Beijing Univ Technol, Coll Chem & Life Sci, Beijing, Peoples R China
[2] Beijing Univ Technol, Beijing Int Sci & Technol Cooperat Base Intelligen, Beijing, Peoples R China
[3] Capital Med Univ, Coll Biomed Engn, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
Drug-eluting stent; Safety; Efficacy; Agent-based model; FINITE-ELEMENT-ANALYSIS; SIMULATION;
D O I
10.1016/j.jbiomech.2024.112304
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
A key strategy for increasing drug mass (DM) while maintaining good safety is to improve the drug release profile (RP). We designed a dual layer coating drug-eluting stent (DES) that exhibited smaller concentration gradients between the coating and the artery wall and significantly impacted the drug RP. However, a detailed understanding of the effects of the DES designed by our team on safety and efficacy is still lacking. The objective of this study was to provide a comprehensive multiscale computational framework that would allow us to probe the safety and efficacy of the DES we designed. This framework consisted of four coupled modules, namely (1) a mechanical stimuli module, simulating mechanical stimuli caused by percutaneous coronary intervention through a finite element analysis, (2) an inflammation module, simulating inflammation of vascular smooth muscle cells (VSMCs) induced by mechanical stimuli through an agent-based model (ABM), (3) a drug transport module, simulating drug transport through a continuum-based approach, and (4) a mitosis module, simulating VSMC mitosis through an ABM. Our results indicated that when the DM increased to two times the initial DM value, the DES we designed had higher safety and lower efficacy values than a conventional DES. When the DM increased to five times the initial DM value, the DES we designed had higher safety than a conventional DES, and negligible differences in efficacy compared with a conventional DES. In summary, the DES we designed exhibited a significant advantage in safety, but a slightly reduced efficacy compared with that of a conventional DES.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Development of a novel drug-eluting stent consisting of an abluminal and luminal coating layer dual therapy system
    Park, Jun-Kyu
    Lee, Jung Ho
    Nah, Jae-Woon
    Kim, Han Ki
    Lim, Kyung Seob
    Bae, In-Ho
    Jeong, Myung Ho
    Unnithan, Afeesh Rajan
    Kim, Cheol Sang
    Park, Chan-Hee
    RSC ADVANCES, 2015, 5 (51): : 40700 - 40707
  • [2] Study of drug-eluting coating on metal coronary stent
    Chen Shanshan
    Tan Lili
    Teng Yingxue
    Zhang Bingchun
    Yang Ke
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2013, 33 (03): : 1476 - 1480
  • [4] Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent
    Heng Ge
    Qing Zhang
    Wei Zhou
    Qing He
    Zhi-hua Han
    Ben He
    Journal of Zhejiang University SCIENCE B, 2010, 11 : 553 - 560
  • [5] Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent
    Ge, Heng
    Zhang, Qing
    Zhou, Wei
    He, Qing
    Han, Zhi-hua
    He, Ben
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2010, 11 (08): : 553 - 560
  • [6] Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent
    Bedair, Tarek M.
    Yu, Seung Jung
    Im, Sung Gap
    Park, Bang Ju
    Joung, Yoon Ki
    Han, Dong Keun
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2015, 460 : 189 - 199
  • [7] Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation
    Ruiz-Nodar, Juan M.
    Marin, Francisco
    Sanchez-Paya, Jose
    Hurtado, Jose A.
    Valencia-Martin, Jose
    Manzano-Fernandez, Sergio
    Roldan, Vanessa
    Perez-Andreu, Virginia
    Sogorb, Francisco
    Valdes, Mariano
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2009, 30 (08) : 932 - 939
  • [8] Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
    Dangas, George
    Baber, Usman
    Sharma, Samin
    Giustino, Gennaro
    Sartori, Samantha
    Nicolas, Johny
    Goel, Ridhima
    Mehta, Shamir
    Cohen, David
    Angiolillo, Dominick J.
    Zhang, Zhongjie
    Camaj, Anton
    Cao, Davide
    Briguori, Carlo
    Dudek, Dariusz
    Escaned, Javier
    Huber, Kurt
    Collier, Timothy
    Kornowski, Ran
    Kunadian, Vijay
    Moliterno, David J.
    Ohman, E. Magnus
    Weisz, Giora
    Gil, Robert
    Krucoff, Mitchell W.
    Kaul, Upendra
    Oldroyd, Keith G.
    Sardella, Gennaro
    Shlofmitz, Richard
    Witzenbichler, Bernhard
    Kastrati, Adnan
    Han, Ya-ling
    Steg, Philippe Gabriel
    Pocock, Stuart
    Gibson, C. Michael
    Mehran, Roxana
    EUROINTERVENTION, 2022, 17 (16) : 1330 - +
  • [9] Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
    Wang, Guozhong
    Zhao, Quanming
    Chen, Qing
    Zhang, Xiaoxia
    Tian, Lei
    Zhang, Xiaojiang
    CORONARY ARTERY DISEASE, 2019, 30 (07) : 473 - 480
  • [10] Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation
    Helft, Gerard
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (05) : 271 - 273